Steven Cohen Sage Therapeutics, Inc. Put Options Transaction History

Point72 Asset Management, L.P.

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q4 2017 Feb 14, 2018	SELL	$60.72 - $167.34 $9.7 Million - $26.7 Million	-159,700 Reduced 77.45%	46,500 $7.66 Million
Q3 2017 Nov 14, 2017	BUY	$61.4 - $88.52 $12.7 Million - $18.3 Million	206,200	206,200 $12.8 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.